Edition:
United States

Ophthotech Corp (OPHT.OQ)

OPHT.OQ on NASDAQ Stock Exchange Global Select Market

2.78USD
24 May 2018
Change (% chg)

$0.00 (+0.18%)
Prev Close
$2.78
Open
$2.79
Day's High
$2.80
Day's Low
$2.76
Volume
10,965
Avg. Vol
51,293
52-wk High
$3.60
52-wk Low
$2.24

Chart for

About

Ophthotech Corporation is a biopharmaceutical company. The Company is engaged in the development of therapeutics to treat ophthalmic diseases, with a focus on diseases of the back of the eye. Its primary focus is developing therapeutics for age-related macular degeneration (AMD), which is a disorder of the central portion of the... (more)

Overall

Beta: 1.39
Market Cap(Mil.): $100.42
Shares Outstanding(Mil.): 36.19
Dividend: --
Yield (%): --

Financials

  OPHT.OQ Industry Sector
P/E (TTM): 0.50 236.60 32.60
EPS (TTM): 5.51 -- --
ROI: 114.25 -7.50 12.74
ROE: -- -10.27 14.66

BRIEF-Ophthotech Reports Q1 Loss Per Share Of $0.36

* OPHTHOTECH REPORTS FIRST QUARTER 2018 FINANCIAL AND OPERATING RESULTS

May 09 2018

BRIEF-Ophthotech Completes Patient Recruitment In A Mid-Stage Trial Of Its Eye Drug Zimura

* OPHTHOTECH COMPLETES PATIENT RECRUITMENT IN THE PHASE 2A CLINICAL TRIAL OF ZIMURA® IN COMBINATION WITH ANTI-VEGF THERAPY IN WET AGE-RELATED MACULAR DEGENERATION

May 01 2018

BRIEF-Ophthotech Reports Posts Q4 Loss Of $0.26 Per Share

* OPHTHOTECH REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL AND OPERATING RESULTS

Feb 27 2018

Earnings vs. Estimates